KBC Group’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $108K | Sell |
2,224
-1,526
| -41% | -$74.1K | ﹤0.01% | 1148 |
|
|
2025
Q1 | $128K | Sell |
3,750
-56,764
| -94% | -$1.94M | ﹤0.01% | 1344 |
|
|
2024
Q4 | $2.38M | Buy |
60,514
+57,696
| +2,047% | +$2.27M | 0.01% | 665 |
|
|
2024
Q3 | $132K | Buy |
2,818
+860
| +44% | +$40.3K | ﹤0.01% | 1118 |
|
|
2024
Q2 | $106K | Buy |
1,958
+351
| +22% | +$19K | ﹤0.01% | 1129 |
|
|
2024
Q1 | $110K | Hold |
1,607
| – | – | ﹤0.01% | 1075 |
|
|
2023
Q4 | $101K | Hold |
1,607
| – | – | ﹤0.01% | 1063 |
|
|
2023
Q3 | $73K | Buy |
+1,607
| New | +$73K | ﹤0.01% | 1157 |
|
|
2021
Q4 | – | Sell |
-600
| Closed | -$67K | – | 1297 |
|
|
2021
Q3 | $67K | Sell |
600
-600
| -50% | -$67K | ﹤0.01% | 1211 |
|
|
2021
Q2 | $194K | Hold |
1,200
| – | – | ﹤0.01% | 1176 |
|
|
2021
Q1 | $146K | Hold |
1,200
| – | – | ﹤0.01% | 1215 |
|
|
2020
Q4 | $1.01M | Sell |
1,200
-1,200
| -50% | -$1.01M | ﹤0.01% | 1145 |
|
|
2020
Q3 | $200K | Hold |
2,400
| – | – | ﹤0.01% | 1118 |
|
|
2020
Q2 | $176K | Buy |
2,400
+1,200
| +100% | +$88K | ﹤0.01% | 1167 |
|
|
2020
Q1 | $51K | Hold |
1,200
| – | – | ﹤0.01% | 1195 |
|
|
2019
Q4 | $73K | Buy |
1,200
+1,035
| +627% | +$63K | ﹤0.01% | 1385 |
|
|
2019
Q3 | $7K | Sell |
165
-1,035
| -86% | -$43.9K | ﹤0.01% | 1461 |
|
|
2019
Q2 | $57K | Hold |
1,200
| – | – | ﹤0.01% | 1345 |
|
|
2019
Q1 | $43K | Hold |
1,200
| – | – | ﹤0.01% | 1328 |
|
|
2018
Q4 | $34K | Hold |
1,200
| – | – | ﹤0.01% | 1243 |
|
|
2018
Q3 | $53K | Hold |
1,200
| – | – | ﹤0.01% | 1327 |
|
|
2018
Q2 | $71K | Sell |
1,200
-500
| -29% | -$29.6K | ﹤0.01% | 1204 |
|
|
2018
Q1 | $78K | Buy |
1,700
+1,000
| +143% | +$45.9K | ﹤0.01% | 1195 |
|
|
2017
Q4 | $16K | Buy |
+700
| New | +$16K | ﹤0.01% | 1242 |
|